INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

PLYMOUTH MEETING, Pa., Nov. 6, 2024/PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that third quarter 2024 financial results will be released after the market close on November 14, 2024. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.

About INOVIO
INOVIOis a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-relateddiseases, cancer, and infectious diseases. INOVIO'stechnology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson(267) 429-8567 [email protected]
Investors: Thomas Hong (267) 440-4298 thomas[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-third-quarter-2024-financial-results-on-november-14-2024-302297260.html

SOURCE INOVIO Pharmaceuticals, Inc.